ArticleJournal for immunotherapy of cancer2025

Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.

Natalie J Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.